Israeli Cannabis-Based Supplements Now Available in the UK via

London, United Kingdom, September 05, 2017 --( CIITECH Ltd, an Israel-based biotech company focused on cannabis research has announced the launch of its UK e-commerce store to distribute a broad range of CBD (Cannabidiol) products based on Israeli science.

Customers can request free CBD samples by registering at

Cannabidiol is a non-psychoactive compound found in both hemp and regular cannabis strains, whose anti-inflammatory properties have become synonymous with medicinal cannabis use. In 2016, the UK’s Home Office accepted the findings of the ACMD (Advisory Council on the Misuse of Drugs) who recommended CBD be taken off the controlled substances act. The MHRA (Medicines and Healthcare products Regulatory Agency) has since accepted the potential therapeutic effect of CBD and suggested it be regulated as a food supplement, opening the market to a range of CBD-based products for consumers’ health and wellness needs.

An estimated 200,000 British citizens consume CBD products regularly for health complaints including pain and anxiety. The UK is understood to be on a pathway to regulate CBD as a food supplement.

Israel is globally recognized as the epicenter of cannabis research, led by Professor Mechoulam at the Hebrew University of Jerusalem for over fifty years. His team’s groundbreaking discovery of the endocannabinoid system in the human body that hosts receptors for cannabinoids was universally acclaimed and paved the way for today’s understanding of the plant’s therapeutic benefits. Israel’s supportive regulatory environment and collaborative healthcare ecosystem place the country at the vanguard of medical cannabis. With full support of their Health Ministry and their start-up nation culture, approvals can be expedited to test the efficacy of cannabis-based products to channel and progress further research in this field.

Clifton Flack, founder of CIITECH says, “For some time, the world has been eager to experience cannabis-based therapeutic products from Israel, widely regarded at the forefront of cannabis research. Due to regulatory obstacles inside Israel, the provision of export has yet to be implemented, leaving consumers without access to products they demand. Today, we’re proud to be the first to offer non-psychoactive, 100% legal (hemp derived) CBD-based products based on Israeli science to UK consumers.”

The UK government remains strongly opposed to ‘medical cannabis’ reform. “Indeed, the likelihood of the UK following in the footsteps of USA, Canada, Israel & Germany in implementing such a program is a long way off, perhaps a scenario we may never see inside UK borders,” continued Flack. offers a range of Israeli cannabis brands including CIITECH’s flagship ‘PROVACAN’ in CBD Oil, e-Liquid and Soothing Balms; the Herbalica range of herbal oils with added CBD have been tested at one of Israel’s largest medicinal cannabis cultivators; VapePod – a cannabis vaporizer with Israeli medical device certification and TrichomeShell, a range of edible products with patented technology for micro-encapsulating CBD.

Go to to register for pre-orders starting from £22.99.

CIITECH is a cannabis biotech company that focuses on discovering, developing and commercializing therapeutic cannabis products. By collaborating with leading research institutions in Israel and local suppliers in U & EU, CIITECH leverages the full potential of Israel’s cutting-edge cannabis innovation. Through its UK based eCommerce shop, Israeli cannabis products are available for the first time and exclusively overseas. Go to for more info.
Diane Mckaye
+44 7771 926726